Legal & General Group
OCDX

Legal & General Group’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Legal & General Group’s Portfolio OCDX Stock Details OCDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-109,440
Closed -$2.04M – 3757
2022
Q1 		$2.04M Buy
109,440
+527
+0.5% +$9.48K ﹤0.01% 1973
2021
Q4 		$2.33M Buy
108,913
+23,558
+28% +$464K ﹤0.01% 1961
2021
Q3 		$1.58M Buy
85,355
+32,189
+61% +$648K ﹤0.01% 2124
2021
Q2 		$1.14M Buy
53,166
+44,064
+484% +$896K ﹤0.01% 2180
2021
Q1 		$176K Buy
+9,102
New +$160K ﹤0.01% 2480

Other funds holding OCDX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Legal & General Group's OCDX Position: Q2 2022 in Review

Legal & General Group sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 109,440 shares — an estimated $2.04M sold.

Legal & General Group first reported a position in OCDX in Q1 2021 and held it in 5 quarters. The position peaked at $2.33M in Q4 2021. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

  • Legal & General Group reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
  • Legal & General Group sold 109,440 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $2.04M.
  • Legal & General Group first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q1 2021 and held it in 5 quarters.
  • Legal & General Group's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $2.33M in Q4 2021.
  • 1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on Legal & General Group's 13F filing for Q2 2022, filed 22 Aug 2022.